Option chain shows key data for Klotho Neurosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Klotho Neurosciences.

Klotho Neurosciences (NASDAQ:KLTO) Stock, Option Chain

Klotho Neurosciences

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

iPad's Impact On Apple

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

AVNW

BHIL

CIFR

CYCN

DECK

DGNX

ENVB

EVTV

KITT

KLTO

ORKT

SLNG

TDTH

TEAM

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

movers image

ATNF

BREA

CLMT

CTCX

EFSH

GEVO

GRTS

LCID

MTEM

PRQR

QNRX

SAIH

STAF

STEC

VINE

VSME

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

BLMZ

CETX

CNEY

CRKN

JTAI

MNTS

MRSN

NMHI

PETZ

SPGC

TVGN

WHLR

Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences Inc

Press Releases

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

Biotech

General

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor

Management

Former Merck USA President Joins Klotho Neurosciences' Board of Directors

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board

Health Care

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

WENA

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

180 Life Sciences

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

GT Biopharma

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Mainz Biomed

Oragenics

Palatin Techs

Sunshine Biopharma

Soligenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Comments

Klotho Neurosciences

Klotho Neurosciences (KLTO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell